get Started

Ferritin

Fibrinogen

Homocysteine

WBC (White Blood Cell Count)

MCV (Mean Corpuscular Volume)

ApoA/ApoB Ratio

Uric Acid

Albumin

Alkaline Phosphatase (ALP)

VLDL Cholesterol (calculated)

Triglycerides

Phosphorous

eGFR (Estimated Glomerular Filtration Rate)

Hemoglobin A1C

HDL Cholesterol

Total Protein

Fasting Insulin

UIBC (Unsaturated Iron Binding Capacity)

A/G Ratio (Albumin/Globulin Ratio)

MCHC (Mean Corpuscular Hemoglobin Concentration)

Reverse T3 (rT3)

Eosinophils (Absolute)

SHBG (Sex Hormone Binding Globulin)

Apolipoprotein A1

Free Testosterone

EPA (Eicosapentaenoic Acid)

DHA (Docosahexaenoic Acid)

Platelet Count

Sed Rate (Erythrocyte Sedimentation Rate)

Serum Cortisol

TIBC (Total Iron Binding Capacity)

Immature Granulocytes

Lipoprotein(a) [Lp(a)]

Hemoglobin

IGF-1 (Insulin-Like Growth Factor 1)

Basophils (Absolute)

Iron Saturation

TNF-α (Tumor Necrosis Factor-alpha)

Insulin

ALT (Alanine Aminotransferase)
"Eosinophils (Absolute) is a valuable biomarker for assessing longevity and overall health. Learn how this biomarker can impact your lifespan and well-being."

Eosinophils (Absolute)

Eosinophils (Absolute) are a type of white blood cell that play a significant role in the body’s immune response. Research has shown that levels of eosinophils can serve as a biomarker for longevity. As we age, the number of eosinophils in the body tends to decrease, and a lower level of eosinophils has been associated with increased mortality risk. Monitoring eosinophil levels over time can provide valuable insights into an individual’s overall health and potential longevity. By incorporating eosinophils as a biomarker in longevity research, scientists and healthcare providers can better understand the aging process and develop personalized strategies for promoting healthy aging.

Biomarker Explained

Eosinophils, a type of white blood cell, have been identified as a potential biomarker for longevity. Research has indicated that lower levels of eosinophils in the body are associated with an increased risk of mortality. As we age, the number of eosinophils tends to decrease, making it an important marker to monitor over time. By incorporating eosinophils into longevity research, scientists and healthcare providers can gain valuable insights into an individual’s overall health and potential for longevity. Tracking eosinophil levels can aid in understanding the aging process and provide the basis for developing personalized strategies to promote healthy aging. Therefore, interpreting and monitoring eosinophil levels can offer crucial information for assessing an individual’s overall health and potential lifespan.

Keywords:

Eosinophils, white blood cells, biomarker, longevity, mortality risk, aging process, personalized strategies

Your Longevity Clinic,
from Home.

Longevity Direct is an app within Longr’s Longevity OS, a platform dedicated to extending access to longevity. 

Verify Approval for www.longevity.direct

Home

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Science
About

Contact

Client portal

© 2025 Longr Holdings Inc.
1007 North Orange Street | DE 19801 | U.S.A

Prescription products require an online consultation with a physician who will determine if a prescription is appropriate. See product page for important safety information. Benefits outlined on Longevity Direct are based on 3rd party studies.

Note: The above statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. If you are in need of emergency medical attention, please call 911 immediately.

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Library
About

get Started
Client portal

Contact

Questions, suggestions, reflections?

Fill out the form below and a member of our team well get back to you as soon as possible.

FAQS
Contact Form (#14)

How does Rapaymcin work?

Rapamycin slows aging by targeting the mTOR pathway, shifting the body’s focus from growth to repair. It promotes cellular recycling, reduces overgrowth linked to disease, and enhances resilience to stress.

Imagine your body as a city, bustling with activity.

Cells are the workers, and mTOR (mechanistic target of rapamycin) is the city planner, deciding where to focus resources – building new structures, cleaning up waste, or repairing old ones.

As we age, mTOR often prioritizes building (cell growth) over maintenance (cellular repair), leading to “clutter” in our bodies that contributes to aging and disease.

This is where Rapamycin comes in.

It acts like a wise advisor to mTOR, convincing it to slow down unnecessary growth projects and focus on clean up and repair instead.

Specifically, Rapamycin:

Activates cellular recycling (autophagy):

Think of autophagy as the city’s waste management system. Damaged parts of cells are broken down and reused, keeping the system efficient and healthy.

Reduces harmful overgrowth:

Overactive mTOR has been linked to diseases such as cancer, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. By dialing back excessive growth signals, Rapamycin helps prevent these issues.

Supports stress resilience:

When cells are less focused on growing, they’re better equipped to handle stress, repair damage, and maintain long-term health.